The following information is exclusively reserved for physicians practicing in Austria, the Netherlands, Spain, and Switzerland where the Zio™ monitor ECG monitoring service is currently authorised and made available for use in accordance with local regulatory requirements.

Learn more

The value of the Zio™ service has been demonstrated in over 135 original scientific research manuscripts.1

Publications


Zio by iRhythm is dedicated to providing clinicians with peer-reviewed scientific evidence. With over 100 publications, Zio is the industry leader that first identified and met the need for long-term continuous monitoring.

Continue the conversation

The Zio™ Service helps you detect arrhythmias earlier, reduce administrative burden, and enhance patient experience — all through a single, streamlined platform.

 

Connect with an iRhythm specialist today to discover how the Zio™ Service can fit into your workflow.

Continue the conversation

Man with child on his shoulders
  1. Data on file. iRhythm Technologies, 2026.

 

The Zio™ service is a long-term continuous ambulatory cardiac monitoring service. It consists of the Zio™ monitor that collects beat-to-beat ECG data and can be worn for up to 14 days; the Zio™ ECG Utilization Service (ZEUS) System deep learned algorithm, which detects arrhythmias. The data is reviewed and curated by a team of Qualified ECG Specialists (QES) to provide the final patient report.

For indications for use, warnings & contraindications, visit here.

iRhythm, Zio, Zio monitor and ZioSuite are trademarks of iRhythm Technologies, Inc. ©2024 All rights reserved.

Zio™ monitor and ZEUS are CE-marked (CE2797).

Zio monitor, ZEUS and Zio service are currently available in Austria, Netherlands, Spain & Switzerland.

For further regulatory information visit here.

WEB0215.01